Pathophysiological role of mast cells in collagen-induced arthritis: Study with a cysteinyl leukotriene receptor antagonist, montelukast
- 24 October 2006
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 548 (1-3), 158-166
- https://doi.org/10.1016/j.ejphar.2006.07.046
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Effect of montelukast on nuclear factor κB activation and proinflammatory moleculesAnnals of Allergy, Asthma & Immunology, 2005
- Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin miceBritish Journal of Pharmacology, 2005
- A role for cardiac mast cells in the pathogenesis of hypertensive heart diseaseJournal of Hypertension, 2003
- Cysteinyl Leukotrienes and Uridine Diphosphate Induce Cytokine Generation by Human Mast Cells Through an Interleukin 4–regulated Pathway that Is Inhibited by Leukotriene Receptor AntagonistsThe Journal of Experimental Medicine, 2002
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- SUPPRESSIVE EFFECTS OF A HERBAL FORMULA, TBL‐1, ON TYPE II COLLAGEN‐INDUCED ARTHRITIS IN DBA/1J MICEClinical and Experimental Pharmacology and Physiology, 1996
- Collagen-Induced Arthritis as a Model of Rheumatoid ArthritisClinical Immunology and Immunopathology, 1994
- Enhanced Synthesis of Cysteinyl Leukotrienes in Juvenile Rheumatoid ArthritisArthritis & Rheumatism, 1994
- Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serumArthritis & Rheumatism, 1988
- Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseasesArthritis & Rheumatism, 1984